Articles |
From the Department of Medicine, Division of Cardiology (S.L.), the Department of Biopharmaceutical Sciences (R.B.M.), and the Department of Pharmacology and Toxicology (S.L., R.H.K.), University of Arkansas for Medical Sciences, Little Rock.
Abstract To elucidate possible mechanisms underlying the cardiotoxicity of terfenadine, the effect of this antihistamine on L-type Ca2+ channel current (ICa,L) was studied in adult rat ventricular myocytes using the whole-cell patch-clamp technique. Myocytes were held at -70 mV and internally dialyzed and externally perfused with Na+- and K+-free solutions; exposure to terfenadine (10-9 to 5x10-6 mol/L) resulted in a concentration-dependent inhibition of peak ICa,L, with a half-maximum inhibition concentration (IC50) of 142 nmol/L. The terfenadine-induced inhibition of ICa,L was not mediated via effects on histamine H1 receptors, because 1 µmol/L triprolidine, a more selective and potent H1 antagonist, had no effect on ICa,L. In this study, we found that terfenadine (1) increased both the fast and slow time constants of ICa,L inactivation, (2) shifted the steady state inactivation of ICa,L to more negative potentials, and (3) elicited a tonic block and a use-dependent block of ICa,L. The terfenadine-induced tonic and use-dependent block and the steady state inhibition of ICa,L were voltage dependent. Both tonic and use-dependent blocks of ICa,L by terfenadine at -40 mV were greater than that at -70 mV, and blocks were partially released by applying a long hyperpolarizing prepulse to -90 mV. These results suggest that terfenadine binds to L-type Ca2+ channels in inactivated and rested states and inhibits ICa,L predominantly by interacting with the inactivated state with an apparent dissociation constant of 60 nmol/L. Open-state block could be observed only at high concentrations of terfenadine. The high-affinity interaction of terfenadine with the inactivated state of L-type Ca2+ channels may play an important role in its cardiotoxicity under pathophysiological conditions, such as ischemia.
Key Words: terfenadine Ca2+ channel cardiac myocyte rat use-dependent block
This article has been cited by other articles:
![]() |
Y.-G. Sun, Y.-X. Cao, W.-W. Wang, S.-F. Ma, T. Yao, and Y.-C. Zhu Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes Cardiovasc Res, September 1, 2008; 79(4): 632 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety Toxicol Pathol, January 1, 2006; 34(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-W. Yu, Q. Chen, R. H Kennedy, and S. J Liu Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes J. Physiol., July 15, 2005; 566(2): 327 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Secondo, M. Taglialatela, M. Cataldi, G. Giorgio, M. Valore, G. Di Renzo, and L. Annunziato Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells Mol. Pharmacol., November 1, 2000; 58(5): 1115 - 1128. [Abstract] [Full Text] |
||||
![]() |
A. A. Grace and A.J. Camm Voltage-gated calcium-channels and antiarrhythmic drug action Cardiovasc Res, January 1, 2000; 45(1): 43 - 51. [Full Text] [PDF] |
||||
![]() |
U. C. Luft, R. Bychkov, M. Gollasch, V. Gross, J.-B. Roullet, D. A. McCarron, C. Ried, F. Hofmann, Y. Yagil, C. Yagil, et al. Farnesol Blocks the L-Type Ca2+ Channel by Targeting the {alpha}1C Subunit Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 959 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishio, Y. Habuchi, H. Tanaka, J. Morikawa, T. Yamamoto, and K. Kashima Blockage by Terfenadine of the Adenosine Triphosphate (ATP)-Sensitive K+ Current in Rabbit Ventricular Myocytes J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 293 - 300. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |